A Becker's Hospital Review round-up lists includes Elizabeth Munro, M.D., Eneida Nemecek, M.D., M.B.A., Linda Stork, M.D., and Tanja Pejovic, M.D., among their list of "exceptional women in oncology."

OHSU signs a $111 million contract amendment with Skanska USA for its hospital expansion project.

A 2022 study led by OHSU researchers is cited in a Vox story on the current shortage of the drug addreall, used to treat attention-deficit hyperactivity disorders.

A new study led by Jane Zhu, M.D., suggests Medicaid reimbursement for the same mental health treatment varies dramatically among U.S. states. Zhu says: “Our study confirms that some states are setting these reimbursement rates quite low, which has implications not just for provider acceptance of Medicaid insurance but also the extent to which they see Medicaid patients."

A new study led by Jane Zhu, M.D., suggests Medicaid reimbursement for the same mental health treatment varies dramatically among U.S. states. Zhu says: “Our study confirms that some states are setting these reimbursement rates quite low, which has implications not just for provider acceptance of Medicaid insurance but also the extent to which they see Medicaid patients."

The Food and Drug Administration authorizes marketing for new treatment of osteoarthritis of the knee, based on nationwide clinical trials, including at OHSU. Dennis Crawford, M.D., says, “Quite frankly, there hasn’t been a substantial development for the treatment of this ubiquitous disease for more than 50 years."

One Community Health, in collaboration with the OHSU Knight Cancer Institute, is recruiting volunteers in the Columbia River Gorge for the Pathfinder 2 early cancer detection study. Laura Ferrara, who works for the Oregon Rural Practice-based Research Network, says: “For years I have dreamed of increasing access to highly innovative clinical trials in the gorge and I'm living the dream working on this one."

A segment from KATU-TV highlights the impact made by Child Life Specialist Jess Calvert, who supports young patients before surgery. She says: "We are the emotional first responders in a medical situation… the ultimate goal is to, through these interventions, have children develop skills, coping skills that they can take into their next encounter.”

Research by Michael Klein, M.D., and others has identified rare genetic variants that may be involved in developing age-related macular degeneration and could be used to develop new therapies.

Parents of a young boy with a rare genetic condition are given a diagnosis at OHSU: the boy's unique hair is the result of uncombable hair syndrome, a condition that affects the shape of hair shafts on the scalp.